Search

everythinglearnresearchcommunity

for

Search:↓

The new rodent model successfully mimics non-lean human PCOS symptoms.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Hair loss in postmenopausal woman caused by ovarian issue.

Traditional Chinese Medicine may help treat hair loss but needs more research.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Female pattern hair loss does not significantly affect sexual dysfunction.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Gray hair regained color after thyroid hormone treatment.

Alopecia patients have less GPER-1, which might affect hair loss.

A new gene, JMJD1C, may affect testosterone levels in men.

Older men with lower levels of available testosterone are more likely to be frail.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Quercetin may help with PCOS symptoms, but more research is needed.